You are using an older browser version. Please use a supported version for the best MSN experience.

Cramer Remix: The new supercharged version of Abbvie is worth a buy

Jim Cramer breaks down why the Abbvie-Allergan tie-up is a better bet at this level than the Bristol Myers-Celgene combination.
image beaconimage beaconimage beacon